Patients Accept Medication-Associated Risk in Exchange for Cure of Symptoms Associated With Rome IV IBS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Alimentary Pharmacology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome
Aliment. Pharmacol. Ther. 2022 Feb 15;[EPub Ahead of Print], VC Goodoory, CE Ng, CJ Black, AC FordFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.